The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs | ||
| dc.conicet.organizacion | University Medical Center Hamburg-Eppendorf | |
| dc.conicet.organizacion | University Medical Center Hamburg-Eppendorf | |
| dc.conicet.organizacion | University Medical Center Hamburg-Eppendorf | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires | |
| dc.conicet.organizacion | University Medical Center Hamburg-Eppendorf | |
| dc.conicet.paisOrganizacion | Alemania | |
| dc.conicet.paisOrganizacion | Alemania | |
| dc.conicet.paisOrganizacion | Alemania | |
| dc.conicet.paisOrganizacion | Argentina | |
| dc.conicet.paisOrganizacion | Alemania | |
| dc.conicet.produccionid | 6667611 | |
| dc.contributor.author | Menzel, Stephan | |
| dc.contributor.author | Rissiek, Björn | |
| dc.contributor.author | Haag, Friedrich | |
| dc.contributor.author | Goldbaum, Fernando Alberto | |
| dc.contributor.author | Koch Nolte, Friedrich | |
| dc.date.accessioned | 2017-09-07T14:07:54Z | |
| dc.date.available | 2017-09-07T14:07:54Z | |
| dc.date.issued | 2013-08 | |
| dc.date.updated | 2017-08-29T15:39:32Z | |
| dc.description.abstract | In 1901, the first Nobel Prize in Physiology or Medicine was awarded to Emil von Behring for his ground-breaking discovery of serum therapy: serum from horses vaccinated with toxin-containing culture medium of Corynebacterium diphtheriae contained life-saving 'antitoxins'. The molecular nature of the ADP-ribosylating toxin and the neutralizing antibodies were unraveled only 50 years later. Today, von Behring's antibody therapy is being refined with a new generation of recombinant antibodies and antibody fragments. Nanobodies, which are single-domain antibodies derived from the peculiar heavy-chain antibodies of llamas and other camelids, are emerging as a promising new class of highly specific enzyme inhibitors. In this review, we illustrate the potential of nanobodies as tools to block extracellular and intracellular ADP-ribosyltransferases (ARTs), using the toxin-related membrane-bound mammalian ecto-enzyme ARTC2 and the actin-ADP-ribosylating Salmonella virulence plasmid factor B toxin of Salmonella enterica as examples. | es |
| dc.description.fil | Fil: Menzel, Stephan. University Medical Center Hamburg-Eppendorf; Alemania | |
| dc.description.fil | Fil: Rissiek, Björn. University Medical Center Hamburg-Eppendorf; Alemania | |
| dc.description.fil | Fil: Haag, Friedrich. University Medical Center Hamburg-Eppendorf; Alemania | |
| dc.description.fil | Fil: Goldbaum, Fernando Alberto. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina | |
| dc.description.fil | Fil: Koch Nolte, Friedrich. University Medical Center Hamburg-Eppendorf; Alemania | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Menzel, Stephan; Rissiek, Björn; Haag, Friedrich; Goldbaum, Fernando Alberto; Koch Nolte, Friedrich; The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs; Wiley Blackwell Publishing, Inc; Febs Journal; 280; 15; 8-2013; 3543-3550 | es |
| dc.identifier.eissn | 1742-4658 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1742-464X | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/23753 | |
| dc.journal.ciudad | Oxford | es |
| dc.journal.number | 15 | es |
| dc.journal.pagination | 3543-3550 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Febs Journal | es |
| dc.journal.volume | 280 | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley Blackwell Publishing, Inc | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/http://onlinelibrary.wiley.com/doi/10.1111/febs.12313 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1111/febs.12313 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | Nanobodies | es |
| dc.subject | Adp-Rybosil Tranferases | es |
| dc.subject | Salmonella | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | The art of blocking ADP-ribosyltransferases (ARTs): nanobodies as experimental and therapeutic tools to block mammalian and toxin ARTs | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.08a23abb-80c4-4977-87df-816376139b5c_A.pdf
- Tamaño:
- 323.68 KB
- Formato:
- Adobe Portable Document Format